[Elsevier] Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-l...

icarus Post time 5 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-22 22:09
Reward10points

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Lancet Oncol




. 2019 Jul;20(7):924-937.

doi: 10.1016/S1470-2045(19)30167-6


https://pubmed.ncbi.nlm.nih.gov/31122901/

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30167-6/abstract

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
jakir_ete_ruet Post time 5 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list